Alcon Inc.

NYSE:ALC Stock Report

Market Cap: US$32.5b

Alcon Valuation

Is ALC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of ALC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: ALC ($66.29) is trading below our estimate of future cash flow value ($100.92)

Significantly Below Future Cash Flow Value: ALC is trading below future cash flow value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ALC?

Key metric: As ALC is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for ALC. This is calculated by dividing ALC's market cap by their current earnings.
What is ALC's PE Ratio?
PE Ratio39.7x
EarningsUS$819.00m
Market CapUS$32.48b

Price to Earnings Ratio vs Peers

How does ALC's PE Ratio compare to its peers?

The above table shows the PE ratio for ALC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average31.9x
MDLN Medline
32.7x19.85%US$48.1b
COO Cooper Companies
56x27.80%US$13.2b
SOLV Solventum
9.3x-5.38%US$13.7b
ALGN Align Technology
29.7x13.08%US$12.5b
ALC Alcon
39.6x18.14%US$25.8b

Price-To-Earnings vs Peers: ALC is expensive based on its Price-To-Earnings Ratio (39.6x) compared to the peer average (31.9x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does ALC's PE Ratio compare vs other companies in the US Medical Equipment Industry?

8 CompaniesPrice / EarningsEstimated GrowthMarket Cap
EMBC Embecta
1.7x-1.95%US$183.92m
LNSR LENSAR
2.4x-68.24%US$70.45m
MBAI Check-Cap
2.5xn/aUS$10.13m
ADVB Advanced Biomed
1.5xn/aUS$7.43m
ALC 39.7xIndustry Avg. 24.5xNo. of Companies8PE01632486480+
8 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: ALC is expensive based on its Price-To-Earnings Ratio (39.6x) compared to the US Medical Equipment industry average (24.5x).

Price to Earnings Ratio vs Fair Ratio

What is ALC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ALC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio39.7x
Fair PE Ratio29.4x

Price-To-Earnings vs Fair Ratio: ALC is expensive based on its Price-To-Earnings Ratio (39.6x) compared to the estimated Fair Price-To-Earnings Ratio (29.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst ALC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$66.29
US$95.78
+44.49%
12.37%US$110.75US$64.17n/a17
Jun ’27US$65.70
US$96.46
+46.82%
12.88%US$112.99US$64.17n/a17
May ’27US$74.09
US$100.26
+35.32%
11.98%US$118.26US$70.34n/a16
Apr ’27US$75.51
US$100.26
+32.77%
11.37%US$118.26US$75.54n/a15
Mar ’27US$87.18
US$99.85
+14.54%
11.53%US$118.26US$75.54n/a15
Feb ’27US$80.98
US$97.56
+20.48%
11.62%US$118.26US$75.54n/a15
Jan ’27US$78.81
US$97.08
+23.18%
12.57%US$118.26US$75.54n/a15
Dec ’26US$78.20
US$100.11
+28.02%
11.41%US$118.26US$79.29n/a15
Nov ’26US$73.89
US$99.96
+35.28%
11.75%US$118.26US$77.75n/a15
Oct ’26US$75.11
US$101.55
+35.20%
12.48%US$123.16US$77.75n/a15
Sep ’26US$79.81
US$101.27
+26.89%
12.38%US$123.16US$77.75n/a15
Aug ’26US$87.87
US$108.86
+23.89%
8.69%US$123.16US$85.75n/a15
Jul ’26US$89.02
US$107.52
+20.78%
8.51%US$123.16US$85.75n/a15
Jun ’26US$85.94
US$105.00
+22.18%
9.16%US$114.29US$83.35US$65.7016
May ’26US$96.17
US$107.70
+11.98%
9.44%US$121.25US$83.35US$74.0915
Apr ’26US$92.70
US$105.15
+13.43%
6.46%US$113.50US$86.19US$75.5116
Mar ’26US$92.50
US$101.46
+9.69%
8.11%US$112.05US$79.46US$87.1816
Feb ’26US$91.09
US$98.70
+8.35%
10.11%US$113.81US$72.43US$80.9816
Jan ’26US$84.89
US$99.04
+16.67%
10.35%US$113.81US$72.43US$78.8116
Dec ’25US$88.85
US$99.36
+11.83%
10.41%US$113.81US$72.43US$78.2016
Nov ’25US$91.79
US$101.87
+10.99%
10.11%US$115.56US$72.73US$73.8915
Oct ’25US$99.12
US$101.77
+2.68%
11.65%US$118.06US$72.73US$75.1115
Sep ’25US$97.68
US$98.89
+1.24%
10.19%US$117.06US$72.73US$79.8115
Aug ’25US$93.82
US$95.37
+1.65%
11.96%US$117.06US$68.41US$87.8715
Jul ’25US$88.07
US$93.71
+6.41%
10.34%US$101.25US$68.41US$89.0215
Jun ’25US$89.13
US$93.42
+4.82%
10.25%US$101.25US$68.41US$85.9416
US$96.09
Fair Value
31.0% undervalued intrinsic discount
17
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/15 21:45
End of Day Share Price 2026/06/15 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alcon Inc. is covered by 58 analysts. 23 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullArgus Research Company
null nullBaird
Jeffrey JohnsonBaird